PT Famon Awal Bros Sedaya TbkISX:PRAY +1.49%87 EBITDA Margin % is 14.85% as of Mar. 2026, which is 22% below its 10-year median of 19.15. GuruFocus rates ISX:PRAY with a GF Score™ of 87/100 and a GF Value™ of Rp873.79 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 668 Healthcare Providers & Services companies, PT Famon Awal Bros Sedaya Tbk ranks better than 58.83% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
PT Famon Awal Bros Sedaya Tbk EBITDA Margin % Related Terms
PT Famon Awal Bros Sedaya Tbk EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Famon Awal Bros Sedaya Tbk EBITDA Margin % Chart
ISX:PRAY vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, PT Famon Awal Bros Sedaya Tbk's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Famon Awal Bros Sedaya Tbk EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Famon Awal Bros Sedaya Tbk's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where PT Famon Awal Bros Sedaya Tbk's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Famon Awal Bros Sedaya Tbk (ISX:PRAY) has a EBITDA Margin % of 14.85% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PT Famon Awal Bros Sedaya Tbk and its competitors. This is 22% below median its historical median of 19.15. Over the past decade, PT Famon Awal Bros Sedaya Tbk's EBITDA Margin % has ranged from 9.38 to 31.86. According to the industry distribution chart, PT Famon Awal Bros Sedaya Tbk ranks #275 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 41.2%.
Is PT Famon Awal Bros Sedaya Tbk's EBITDA Margin % too high?
PT Famon Awal Bros Sedaya Tbk's current EBITDA Margin % of 14.85% is 22% below median its 10-year median of 19.15. Over the past 10 years, this metric has ranged from a low of 9.38 to a high of 31.86. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. PT Famon Awal Bros Sedaya Tbk's value of 14.85% is 45.4% above this industry median. Based on the distribution chart, PT Famon Awal Bros Sedaya Tbk ranks #275 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, PT Famon Awal Bros Sedaya Tbk has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Famon Awal Bros Sedaya Tbk's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Famon Awal Bros Sedaya Tbk ranks #275 out of 668 companies for EBITDA Margin %. This puts PT Famon Awal Bros Sedaya Tbk in the upper half of its industry. The industry median EBITDA Margin % is 10.21. PT Famon Awal Bros Sedaya Tbk's value of 14.85% is 45.4% above this benchmark. Historically, PT Famon Awal Bros Sedaya Tbk's own EBITDA Margin % has ranged from 9.38 to 31.86 over the past decade. While the company's 10-year median is 19.15 vs. the industry median of 10.21, PT Famon Awal Bros Sedaya Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Famon Awal Bros Sedaya Tbk's current EBITDA Margin % of 14.85% is 45.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PT Famon Awal Bros Sedaya Tbk and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Famon Awal Bros Sedaya Tbk's current EBITDA Margin % is 14.85%, which is 22% below median its own 10-year median of 19.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Famon Awal Bros Sedaya Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Famon Awal Bros Sedaya Tbk (ISX:PRAY) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp873.79, compared to a current price of Rp680.00 — trading 22.2% below its estimated fair value. The current EBITDA Margin % is 14.85%, which is 22% below median its 10-year median of 19.15 and 45.4% above the Healthcare Providers & Services industry median of 10.21. PT Famon Awal Bros Sedaya Tbk's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For PT Famon Awal Bros Sedaya Tbk (ISX:PRAY), the current EBITDA Margin % is 14.85% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Famon Awal Bros Sedaya Tbk (ISX:PRAY) Overvalued in 2026?
Based on GuruFocus' analysis, PT Famon Awal Bros Sedaya Tbk stock appears to be undervalued.
The current stock price of Rp680.00 is trading 22.2% below its estimated GF Value™ of Rp873.79.
GuruFocus considers PT Famon Awal Bros Sedaya Tbk to be Modestly Undervalued.
Key valuation signals for ISX:PRAY:
EBITDA Margin %: 14.85% (22% below median its 10-year median of 19.15)
GF Value™: Rp873.79 vs. price of Rp680.00 (22.2% below fair value)
Industry Position: 45.4% above the Healthcare Providers & Services median (#275 of 668)
No single metric tells the full story. See the ISX:PRAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Famon Awal Bros Sedaya Tbk Business Description
PT Famon Awal Bros Sedaya Tbk operates as a hospital. The company7 provides comprehensive health services for Indonesians and foreign nationals (foreigners) and provides patient services with guarantees from companies, insurance, BPJS, and personal payments. Its hospital network has spread across different cities in Indonesia, including Jakarta, Bekasi, Tangerang, Semarang, Sukabumi, Makassar, Palangkaraya, and Pangkal Pinang. The services that it provides for patients include heart and blood vessel service centers, mother and child services, sports clinic & orthopedic services, cancer services, eye care centers & urology centers. The company's segments are Java; Kalimantan dan/ and Sulawesi; and Sumatera. It derives maximum revenue from Jawa.
87GF Score
Get the complete analysis for ISX:PRAY
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PRAY has been successfully added to your 
